New product licenses total 670 in first half

Even amid data fabrication of bioequivalence, licenses for new products in the first half of this year totaled 670 items, according to a report released by the Korea Food and Drug Administration (KFDA).

Details of new product licenses in the January-June period were as follows: 98 items in January, 193 items in February, 109 items in March, 21 items in April, 111 items in May and 138 items i...